CP-174 Healthcare professionals’ knowledge of intravenous fluid treatment
نویسندگان
چکیده
منابع مشابه
Knowledge of healthcare professionals about rights of patient’s images
Objective To assess knowledge of healthcare professionals about capture and reproduction of images of patients in a hospital setting. Methods A cross-sectional and observational study among 360 healthcare professionals (nursing staff, physical therapists, and physicians), working at a teaching hospital in the city of São Paulo (SP). A questionnaire with sociodemographic information was distribu...
متن کاملKnowledge of healthcare professionals about medication errors in hospitals
CONTEXT Medication errors are the most common types of medical errors in hospitals and leading cause of morbidity and mortality among patients. AIMS The aim of the present study was to assess the knowledge of healthcare professionals about medication errors in hospitals. SETTINGS AND DESIGN A self-administered questionnaire was distributed to randomly selected healthcare professionals in ei...
متن کاملFuture healthcare professionals' knowledge about the Argentinean abortion law.
OBJECTIVE We assessed healthcare students' knowledge and opinions on Argentinian abortion law and identified differences between first- and final-year healthcare students. METHODS In this cross-sectional study, self-administered anonymous questionnaires were administered to 760 first- and 695 final-year students from different fields of study (medicine, midwifery, nursing, radiology, nutritio...
متن کامل[Dental treatment of pregnant women: the role of healthcare professionals].
The scope of this article involved qualitative research conducted together with pregnant women attended by the Brazilian Unified Health System (SUS) and private services, seeking to identify the perception of these women on the role of health professionals in relation to dental care during pregnancy. The data were collected through recorded, semi-structured interviews based on a questionnaire a...
متن کاملInformation for Healthcare Professionals
Has the medication received US Food and Drug Administration (FDA) approval? If so, what are the indications and uses? Yes . On November 14, 2014, the FDA approved alemtuzumab for treatment of relapsing forms of multiple sclerosis (MS). Because of its safety profile, alemtuzumab should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Hospital Pharmacy
سال: 2015
ISSN: 2047-9956,2047-9964
DOI: 10.1136/ejhpharm-2015-000639.165